“Heart failure is a disease with a low survival rate, and a new treatment option is very meaningful. In a clinical study, Forxiga showed additional benefit, in addition to the existing standard care, in heart failure. If clinicians apply the results to patient care, the drug will significantly contr
Helismith said HX106, its adjuvant therapy for treating impulsive behavior, has proven efficacy in treating attention deficit hyperactivity disorder (ADHD), especially when used together with methylphenidate.Its research team conducted clinical trials by administering HX106 on two groups of 29 ADHD
Korean manufacturers of biosimilars have begun conducting global trials to expedite commercializing their pipelines.Their moves are part of the preparation to release biosimilars referencing original blockbuster drugs such as Stelara (ustekinumab), Prolia (denosumab), and Avastin (bevacizumab), whic
Daewoong Pharmaceutical said it has won the approval to conduct phase 3 clinical trials of Foistar® tablets, the first oral medication preventing Covid-19 from the Ministry of Food and Drug Safety. The company will carry out the trial on 1,012 people in self-quarantine after being exposed to the cor
MSD Korea said it would pay 15 million won ($13,600) to each employee transferring to its spinoff, Organon Korea.Last Friday, the company agreed with its labor union to provide incentives on top of the workers' monthly wage in February. The management and the union also agreed to guarantee the job s
Gilead Sciences Korea’s hepatitis B treatment Vemlidy (ingredient: tenofovir ala fenamide, TAF), a follow-up to Viread, continued to achieve expansion in prescriptions for the third year in 2020.However, prescriptions of Vemlidy in 2020 were only one-third of those of Viread. This indicates that Vem
Colchicine, commonly used to treat gout, reduced the risk of hospitalizations or death in Covid-19 patients, a study showed. The study results could make colchicine the only oral drug that proved efficacy against Covid-19.On Saturday, the Montreal Heart Institute (MHI) released the results of the CO
Dong-A ST said Monday it has won approval to conduct a phase 3 clinical trial of DMB-3115, its chronic psoriasis treatment, from the U.S. Food and Drug Administration.The pipeline is a biosimilar drug of Stelara® (Ustekinumab), developed by Janssen Pharmaceutica. Stelara is a blockbuster drug with 7
Genexine said Friday that it would start developing GX-170, a next-generation DNA vaccine preventing tuberculosis, in joint efforts with Yonsei University. The company has secured candidate materials for the tuberculosis vaccine and completed its patent application, with the support of Yonsei Univer
The Korea Disease Control and Prevention Agency (KDCA) said Friday that SK Bioscience would distribute the Covid-19 vaccines.Since the storage and distribution conditions of the Covid-19 vaccines are different by manufacturer, and the vaccination locations for each vaccine are diverse, there was a h
JW Pharmaceutical said the Ministry of Health and Welfare has decided to expand insurance coverage for its type-A hemophilia treatment, Hemlibra.Under the old guidelines, insurance benefits were limited to patients over 12 and weighed 40 kilograms or more, those with 5BU/ml of antibody potency, and
GC said that it has become the first company in the world to receive a license in Japan for its treatment of Hunter syndrome using a ventricular injection.The approval comes after Professor Okuyama Torayuki of Japan's National Center for Child Health and Development confirmed the Hunterase ICV reduc
Korean pharmaceutical companies are briskly signing co-promotion deals with one another to expand sales outlets and preempt advantageous positions in markets. On Thursday, Yuyu Pharma and Alvogen Korea made a co-promotion deal for joint marketing of the latter's Evista (ingredient: raloxifene) and B
Hanmi Pharmaceutical kept the lead in the prescription drug market in 2020 for three consecutive years despite the Covid-19 pandemic thanks to its new combination drugs’ robust performances.Midsize drugmakers, including HK inno.N, also recorded solid sales growth, while traditional giants faltered l
AngioLab Inc. said it has won the patent concerning the use of paeonol for inhibiting angiogenesis or enhancing radiosensitization from the U.S. Patent and Trademark Office.AngioLab will use paeonol, a phenolic compound from peonies, to develop a radiation-sensitive treatment that reduces toxicity a
Cooperation among local pharmaceutical companies and artificial intelligence firms to develop new drugs are heating up from the start of 2021.One drugmaker after another has already signed an agreement with AI-based medicine developers to shorten the time and cost required for producing new drug can
Daewoong Pharmaceutical is attracting industry watchers' interest after it applied for the off-label prescription of Foistar (ingredient: camostat mesylate), a pancreatic drug being developed for treating Covid-19.Off-label prescription is made when physicians prescribe or administer a drug for purp
Lunit said Wednesday that it has agreed with GI Innovation to develop innovative new medicines jointly.Under the accord, the two companies will use GI Innovation's two dual fusion protein platforms -- GI-SMART and SMAR-Tab -- and Lunit's artificial intelligence-based tissue analysis system, Lunit Sc
Hanall Biopharma said its sales and operating profit suffered a heavy blow last year because of the Covid-19 pandemic.According to the company’s provisional performance disclosure on Tuesday, its 2020 sales dropped 18.5 percent from 2019 to 88.3 billion won ($80.1 million) and operating profit plung
Despite the Covid-19 pandemic, Korea's medicine export marked an all-time high of $7.4 billion last year, an increase of 74.4 percent from 2019. The nation’s monthly drug export had continued to rise to surpass $500 million for the first time in March last year. It took less than a year for the mont